Join
Live feed
·
PRReleasevia Quantisnow
TuHURA Biosciences Inc. logo

TuHURA Files Investigational New Drug Application for TBS-2025 in the Treatment of Blood-Related Cancers

ByQuantisnow·Wall Street's wire, on your screen.
HURA· TuHURA Biosciences Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track HURA (TuHURA Biosciences Inc.) and more on Quantisnow.